Equities

Nippon Chemiphar Co Ltd

4539:TYO

Nippon Chemiphar Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,583.00
  • Today's Change1.00 / 0.06%
  • Shares traded900.00
  • 1 Year change-16.24%
  • Beta0.7225
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(202)480976
Depreciation/depletion1,4591,5001,586
Non-Cash items(231)(728)(213)
Cash taxes paid, supplemental(130)484390
Cash interest paid, supplemental145120118
Changes in working capital(729)(2168)(548)
Total cash from operations297(916)1,801
INVESTING
Capital expenditures(2636)(1014)(727)
Other investing and cash flow items, total(503)620762
Total cash from investing(3139)(394)35
FINANCING
Financing cash flow items(92)(86)(74)
Total cash dividends paid(182)(183)(182)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net1,721413(537)
Total cash from financing1,447144(793)
NET CHANGE IN CASH
Foreign exchange effects665196
Net change in cash(1329)(1115)1,139
Net cash-begin balance/reserved for future use10,52911,64510,505
Net cash-end balance/reserved for future use9,20010,52911,645
SUPPLEMENTAL INCOME
Depreciation, supplemental1,4591,5001,586
Cash interest paid, supplemental145120118
Cash taxes paid, supplemental(130)484390
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.